Tarsa Therapeutics, Inc.

ACTIVE

8 Penn Ctr 1628 John F Kennedy Blvd Ste 1400, 宾夕法尼亚州费拉德尔菲亚县, Pennsylvania, United Stateswww.tarsatherapeutics.comSubsidiary11–50 employeesEstablished: 2009-01-01

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2009

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

42.9%

Phase 3

14.3%

Trial Status Distribution

Active, not recruiting

42.9%

Completed

57.1%

Clinical Trials

Trials sponsored by this organization (7)

A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis

Phase 2

Completed

interventional

Jan 2011129 participants

A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women

Phase 3

Completed

interventional

Jun 2009565 participants

A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Parallel Group, 48 Week, Study of Oral Recombinant sCT Compared to Calcitonin Nasal Spray in Postmenopausal Osteoporotic Women - A Comparison of Oral and Nasal Calcitonin in Postmenopausal Osteoporotic Wome

Active, not recruiting

May 2009550 participants

A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Parallel Group, 48 Week, Study of Oral Recombinant Calcitonin (rsCT) Compared to Calcitonin Nasal Spray in Postmenopausal Osteoporotic Women - A Comparison of Oral and Nasal Calcitonin in Postmenopausal Osteoporotic Wome

Active, not recruiting

Apr 2009550 participants

A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Parallel Group, 48 Week, Study of Oral Recombinant Calcitonin (rsCT) Compared to Calcitonin Nasal Spray in Postmenopausal Osteoporotic Women - A Comparison of Oral and Nasal Calcitonin in Postmenopausal Osteoporotic Wome

Active, not recruiting

Jan 2009550 participants

A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women

Phase 2

Completed

interventional

Dec 200812 participants

A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women

Phase 2

Completed

interventional

Feb 200824 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations